131 related articles for article (PubMed ID: 16958135)
1. Hepatitis C virus--biology, host evasion strategies, and promising new therapies on the horizon.
Qureshi SA
Med Res Rev; 2007 May; 27(3):353-73. PubMed ID: 16958135
[TBL] [Abstract][Full Text] [Related]
2. Treatment and vaccination for hepatitis C: present and future.
Jawaid A; Khuwaja AK
J Ayub Med Coll Abbottabad; 2008; 20(1):129-33. PubMed ID: 19024206
[TBL] [Abstract][Full Text] [Related]
3. The hepatitis C virus life cycle as a target for new antiviral therapies.
Pawlotsky JM; Chevaliez S; McHutchison JG
Gastroenterology; 2007 May; 132(5):1979-98. PubMed ID: 17484890
[TBL] [Abstract][Full Text] [Related]
4. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
[TBL] [Abstract][Full Text] [Related]
5. Current and future concepts in hepatitis C therapy.
Pawlotsky JM
Semin Liver Dis; 2005 Feb; 25(1):72-83. PubMed ID: 15731999
[TBL] [Abstract][Full Text] [Related]
6. Rapid virologic response: a new milestone in the management of chronic hepatitis C.
Poordad F; Reddy KR; Martin P
Clin Infect Dis; 2008 Jan; 46(1):78-84. PubMed ID: 18171217
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus virology and new treatment targets.
Meier V; Ramadori G
Expert Rev Anti Infect Ther; 2009 Apr; 7(3):329-50. PubMed ID: 19344246
[TBL] [Abstract][Full Text] [Related]
8. Present and future therapy for hepatitis C virus.
Cornberg M; Deterding K; Manns MP
Expert Rev Anti Infect Ther; 2006 Oct; 4(5):781-93. PubMed ID: 17140355
[TBL] [Abstract][Full Text] [Related]
9. Presence of hepatitis C virus (HCV)-RNA in peripheral blood mononuclear cells in HCV serum negative patients during interferon and ribavirin therapy.
Januszkiewicz-Lewandowska D; Wysocki J; Pernak M; Nowicka K; Zawada M; Rembowska J; Lewandowski K; Mańkowski P; Nowak J
Jpn J Infect Dis; 2007 Feb; 60(1):29-32. PubMed ID: 17314422
[TBL] [Abstract][Full Text] [Related]
10. Serine protease inhibitors as anti-hepatitis C virus agents.
Reiser M; Timm J
Expert Rev Anti Infect Ther; 2009 Jun; 7(5):537-47. PubMed ID: 19485794
[TBL] [Abstract][Full Text] [Related]
11. New therapies for hepatitis C virus infection.
Soriano V; Peters MG; Zeuzem S
Clin Infect Dis; 2009 Feb; 48(3):313-20. PubMed ID: 19123867
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus genetic variability in patients undergoing antiviral therapy.
Cristina J; del Pilar Moreno M; Moratorio G
Virus Res; 2007 Aug; 127(2):185-94. PubMed ID: 17449128
[TBL] [Abstract][Full Text] [Related]
13. Antiviral combination therapy for treatment of chronic hepatitis B, hepatitis C, and human immunodeficiency virus infection.
Hofmann WP; Soriano V; Zeuzem S
Handb Exp Pharmacol; 2009; (189):321-46. PubMed ID: 19048206
[TBL] [Abstract][Full Text] [Related]
14. Treatment of chronic hepatitis B or C in HIV-infected patients with dual viral hepatitis.
Soriano V; Barreiro P; Martín-Carbonero L; Castellares C; Ruiz-Sancho A; Labarga P; Ramos B; Gonzalez-Lahoz J
J Infect Dis; 2007 Apr; 195(8):1181-3. PubMed ID: 17357055
[TBL] [Abstract][Full Text] [Related]
15. Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response.
Landau DA; Saadoun D; Halfon P; Martinot-Peignoux M; Marcellin P; Fois E; Cacoub P
Arthritis Rheum; 2008 Feb; 58(2):604-11. PubMed ID: 18240235
[TBL] [Abstract][Full Text] [Related]
16. Chemical genetics approach to hepatitis C virus replication: cyclophilin as a target for anti-hepatitis C virus strategy.
Watashi K; Shimotohno K
Rev Med Virol; 2007; 17(4):245-52. PubMed ID: 17299803
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus: prospects for future therapies.
Wilkinson T
Curr Opin Investig Drugs; 2001 Nov; 2(11):1516-22. PubMed ID: 11763151
[TBL] [Abstract][Full Text] [Related]
18. Virological relapse in chronic hepatitis C.
Poordad FF; Flamm SL
Antivir Ther; 2009; 14(3):303-13. PubMed ID: 19474464
[TBL] [Abstract][Full Text] [Related]
19. A primer on the molecular virology of hepatitis C.
Moradpour D; Blum HE
Liver Int; 2004 Dec; 24(6):519-25. PubMed ID: 15566499
[TBL] [Abstract][Full Text] [Related]
20. HCV's days are numbered: next-generation direct-acting antivirals and host-targeting agents.
Calle Serrano B; Manns MP
Antivir Ther; 2012; 17(6 Pt B):1133-46. PubMed ID: 23188760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
